AKRO - Akero Therapeutics EPS misses by $1.76 August, 12 2019 07:08 AM Akero Therapeutics Inc. Akero Therapeutics (NASDAQ:AKRO): Q2 GAAP EPS of -$2.21 misses by $1.76.Cash and cash equivalents of $162.6MPress ReleaseMore news on: Akero Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,